(Q39656626)

13 September 2017

title

Tamoxifen reverses the multi-drug-resistance of an established human cholangiocarcinoma cell line in combined chemotherapeutics (English)

1 reference

13 September 2017

0 references

multiple drug resistance

1 reference

1 reference

1 reference

Zhi-Hua Liu

1

1 reference

13 September 2017

Yan-Lei Ma

2

1 reference

13 September 2017

Yan-Ping He

3

1 reference

13 September 2017

Peng Zhang

4

1 reference

13 September 2017

Yu-Kun Zhou

5

1 reference

13 September 2017

Huanlong Qin

6

1 reference

13 September 2017

publication date

14 September 2010

1 reference

Molecular Biology Reports

13 September 2017

published in

1 reference

13 September 2017

volume

38

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

1769-1775

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-010-0291-z

13 September 2017

exact match

0 references

cites work

Biliary tract cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

Acquired cellular resistance to flavopiridol in a human colon carcinoma cell line involves up-regulation of the telomerase catalytic subunit and telomere elongation. Sensitivity of resistant cells to combination treatment with a telomerase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

The growth-inhibition effect of tamoxifen in the combination chemotherapeutics on the human cholangiocarcinoma cell line QBC939.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

The epidemiology of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

Antiproliferation and apoptosis induced by tamoxifen in human bile duct carcinoma QBC939 cells via upregulated p53 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

Centromere anatomy in the multidrug-resistant pathogen Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

Comparative genomics of the IncA/C multidrug resistance plasmid family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

Enhancement of cytotoxicity of natural product drugs against multidrug resistant variant cell lines of human head and neck squamous cell carcinoma and breast carcinoma by tesmilifene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

Effects of oral Lactobacillus plantarum on hepatocyte tight junction structure and function in rats with obstructive jaundice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

A new mechanism of action for tamoxifen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

Magnetic cell separation using nano-sized bacterial magnetic particles with reconstructed magnetosome membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0291-Z

P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.

21 January 2018

1 reference

12 December 2020

Establishment and identification of the human multi-drug-resistant cholangiocarcinoma cell line QBC939/ADM.

1 reference

12 December 2020

Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma

1 reference

12 December 2020

1 reference

12 December 2020

Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms

1 reference

12 December 2020

Treatment strategy for patients with middle and lower third bile duct cancer

1 reference

12 December 2020

10.1007/S11033-010-0291-Z

Identifiers

DOI

1 reference

13 September 2017

1 reference